Value of multiparametric MRI in the work-up of prostate cancer

Current Urology Reports

Volumn 13, Issue 1, 2012, Pages 82-92

  Cornud, F ^a   Delongchamps, N B ^a   Mozer, P ^b   Beuvon, F ^a   Schull, A ^a   Muradyan, N ^c   Peyromaure, M ^a  

^a université Paris Cité   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c ICAD INC   (United States)

Author keywords

D'Amico criteria; Magnetic resonance imaging; MRI; Multiparametric MRI; Prebiopsy MRI; Prostate cancer; Transrectal ultrasound; TRUS MRI image fusion

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BRACHYTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RISK; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; GLEASON SCORE; HUMAN; IMAGE PROCESSING; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SURGERY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY; TUMOR ABLATION; TUMOR DIFFERENTIATION; TUMOR VOLUME;

HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM GRADING; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 84857635225     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-011-0231-z     Document Type: Article

References (47)

1. Afaq A, Koh DM, Padhani A, van As N, Sohaib SA. Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer. BJU Int. 2011 Jun 1
2. AV D'Amico AA Renshaw K Cote M Hurwitz C Beard M Loffredo, et al. 2004 Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 22 18 3726 32 10.1200/JCO.2004.01.164 (Pubitemid 41095213)
3. JR Stark S Perner MJ Stampfer JA Sinnott S Finn AS Eisenstein, et al. 2009 Gleason score and lethal prostate cancer: does 3∈+∈4∈= ∈4∈+∈3? J Clin Oncol 27 21 3459 64 19433685 10.1200/JCO.2008.20. 4669 For prostatectomy specimens, 4∈+∈3 cancers were associated with a threefold increase in lethal prostate cancer compared with 3∈+∈4 cancers. This important finding has led to classify tumors with a Gleason score 7, 4∈+∈3 on TRUS-guided biopsies in the high-risk group
4. JI Epstein DW Chan LJ Sokoll PC Walsh JL Cox H Rittenhouse, et al. 1998 Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings J Urol 160 6 Pt 2 2407 11 9817393 1:STN:280:DyaK1M%2Fjt1ejtw%3D%3D (Pubitemid 29483051)
5. N Lawrentschuk MA Haider N Daljeet A Evans A Toi A Finelli, et al. 2010 'Prostatic evasive anterior tumours': the role of magnetic resonance imaging BJU Int 105 9 1231 6 19817743 10.1111/j.1464-410X.2009.08938.x This is one of the first papers to suggest that tumor burden of anterior tumors was commonly underestimated by a standard 12 posterior core sextant biopsy protocol
6. R Alonzi AR Padhani C Allen 2007 Dynamic contrast enhanced MRI in prostate cancer Eur J Radiol 63 3 335 50 17689907 10.1016/j.ejrad.2007.06.028 (Pubitemid 47321040)
7. M Seitz A Shukla-Dave A Bjartell K Touijer A Sciarra PJ Bastian, et al. 2009 Functional magnetic resonance imaging in prostate cancer European urology [Review] 55 4 801 14 10.1016/j.eururo.2009.01.027 1:CAS:528:DC%2BD1MXnvVWqs7g%3D
8. J Noldus M Graefen A Haese RP Henke P Hammerer H Huland 2000 Stage migration in clinically localized prostate cancer Eur Urol 38 1 74 8 10859445 10.1159/000020255 1:STN:280:DC%2BD3czpsFWqtA%3D%3D (Pubitemid 30418019)
9. V Scattoni A Zlotta R Montironi C Schulman P Rigatti F Montorsi 2007 Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature Eur Urol 52 5 1309 22 17720304 10.1016/j.eururo.2007.08.006 (Pubitemid 47446019)
10. G Giannarini R Autorino G di Lorenzo 2009 Saturation biopsy of the prostate: why saturation does not saturate Eur Urol 56 4 619 21 19327882 10.1016/j.eururo.2009.03.044
11. NB Delongchamps G de la Roza R Jones M Jumbelic GP Haas 2009 Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer BJU Int 103 1 49 54 18680497 10.1111/j.1464-410X.2008.07900.x The evaluation of saturation biopsies based on the true prevalence of prostate cancer showed no increase in detection rate over a less extensive 18-core biopsy
12. NB Delongchamps F Beuvon D Eiss T Flam N Muradyan M Zerbib, et al. 2011 Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer Prostate cancer and prostatic diseases. 14 3 232 7 21423266 10.1038/pcan.2011.9 1:STN:280: DC%2BC3MjmtlKkug%3D%3D With optimal MR combinations, tumor size was correctly estimated in 77% of tumor foci involving more than one octant. Bilateral tumors were detected in 80% (16/20) of cases. In patients with unilateral low-risk prostate cancer on biopsy, multiparametric MRI can help to predict bilateral involvement.
13. • Delongchamps NB, Rouanne M, Flam T, Beuvon F, Liberatore M, Zerbib M, et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int. 2010 Nov 2. Adding DWI and DCE to T2W imaging significantly increased MRI performance in cancer detection in the PZ.
14. JJ Futterer SW Heijmink TW Scheenen J Veltman HJ Huisman P Vos, et al. 2006 Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging Radiology 241 2 449 58 16966484 10.1148/radiol.2412051866 (Pubitemid 44632891)
15. A Villers P Puech D Mouton X Leroy C Ballereau L Lemaitre 2006 Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings J Urol 176 6 Pt 1 2432 7 17085122 10.1016/j.juro.2006.08. 007 (Pubitemid 44665992)
16. N Girouin F Mege-Lechevallier A Tonina Senes A Bissery M Rabilloud JM Marechal, et al. 2007 Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? Eur Radiol 17 6 1498 509 17131126 10.1007/s00330-006-0478-9 (Pubitemid 46767598)
17. MA Haider TH van der Kwast J Tanguay AJ Evans A-T Hashmi G Lockwood, et al. 2007 Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate Cancer Am J Roentgenol 189 2 323 8 10.2214/AJR.07.2211 (Pubitemid 47195916)
18. T Yoshizako A Wada T Hayashi K Uchida M Sumura N Uchida, et al. 2008 Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer Acta radiologica. Evaluation Studies 49 10 1207 13 1:STN:280:DC%2BD1cjmt1Knuw%3D%3D
19. NM deSouza SF Riches NJ Vanas VA Morgan SA Ashley C Fisher, et al. 2008 Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer Clin Radiol 63 7 774 82 18555035 10.1016/j.crad.2008.02.001 1:STN:280:DC%2BD1czos1Ohsg%3D%3D
20. IT Koksal F Ozcan TC Kadioglu T Esen I Kilicaslan M Tunc 2000 Discrepancy between Gleason Scores of Biopsy and Radical Prostatectomy Specimens Eur Urol 37 6 670 4 10828666 10.1159/000020216 1:STN:280:DC%2BD3cvhtF2ksw%3D%3D (Pubitemid 30255783)
21. Hambrock T, Hoeks C, Hulsbergen-van de Kaa C, Scheenen T, Futterer J, Bouwense S, et al. Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging-Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort. European urology. 2011 Aug 27.
22. S Verma A Rajesh H Morales L Lemen G Bills M Delworth, et al. 2011 Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy AJR Am J Roentgenol. 196 2 374 81 21257890 10.2214/AJR.10.4441
23. •• Giles SL, Morgan VA, Riches SF, Thomas K, Parker C, deSouza NM. Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components. AJR American journal of roentgenology. Research Support NonUS Gov't 2011;196(3):586-91. In patients managed by active surveillance, repeat biopsies showed that both fast and slow diffusion components were significantly lower in tumors that were subsequently upgraded on histology. On DWI-MRI, both tumor volume and the true diffusion ADC (slow) were significant but independent predictors of histologic progression.
24. TJ Polascik JM Mayes FR Schroeck L Sun JF Madden JW Moul, et al. 2009 Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy Cancer 115 10 2104 10 19288576 10.1002/cncr.24258
25. MR Engelbrecht GJ Jager RJ Laheij AL Verbeek HJ Van Lier JO Barentsz 2002 Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis Eur Radiol 12 9 2294 302 12195484 (Pubitemid 36940327)
26. A Graser A Heuck B Sommer J Massmann J Scheidler M Reiser, et al. 2007 Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology AJR Am J Roentgenol. 188 1 84 90 17179349 10.2214/AJR.06.0401 (Pubitemid 46012493)
27. AP Labanaris K Engelhard V Zugor R Nutzel R Kuhn 2010 Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate Prostate Cancer Prostatic Dis. 13 1 65 70 19752886 10.1038/pcan.2009.41 1:STN:280:DC%2BC3c%2FpsFyrsQ%3D%3D
28. V Azancot M Peyromaure E Xylinas A Descazeaud F Cornud A Vieillefond, et al. 2009 Analysis of anatomopathological results of radical prostatectomy specimen of patients who answer to criteria for active surveillance of prostate cancer Prog Urol 19 9 619 23 19800552 10.1016/j.purol.2009.05.011 1:STN:280:DC%2BD1MnmslSkuw%3D%3D
29. GJ Jager ET Ruijter CA van de Kaa JJ de la Rosette GO Oosterhof JR Thornbury, et al. 1996 Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology AJR Am J Roentgenol. 166 4 845 52 8610561 1:STN:280:DyaK287pvV2rtg%3D%3D (Pubitemid 26102064)
30. Fuchsjager MH, Shukla-Dave A, Hricak H, Wang L, Touijer K, Donohue JF, et al. Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy. BJU international. [Evaluation Studies Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. 2009 Aug;104(3):315-20.
31. S Kirac Y Duman I Cureklibatur D Yuksel O Nazli G Gunaydin, et al. 1997 Detection of metastatic bone lesions in patients with prostate carcinoma: 99Tcm-monoclonal antibody imaging. Nuclear medicine communications Clinical Trial. 18 10 968 73 1:STN:280:DyaK1c%2FlsVGisg%3D%3D (Pubitemid 27497513)
32. Cornud F, Rouanne M, Beuvon F, Eiss D, Flam T, Liberatore M, et al. Endorectal 3D T2-weighted 1 mm-slice thickness MRI for prostate cancer staging at 1.5Tesla: Should we reconsider the indirects signs of extracapsular extension according to the D'Amico tumor risk criteria? European journal of radiology. 2011 Aug 24.
33. Cornud F, Rouanne M, Beuvon F, Eiss D, Flam T, Liberatore M, et al. Endorectal 3D T2-Weighted 1 mm-slice thickness MRI for prostate cancer staging at 1.5 Tesla: should we reconsider the indirects signs of extracapsular extension according to the D'Amico tumor risk criteria? Eur J Radiology. 2011;in press.
34. J Ren Y Huan H Wang Y Ge Y Chang H Yin, et al. 2009 Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imaging Eur Radiol 19 10 2481 6 19513720 10.1007/s00330-009-1428-0
35. AM Hovels RA Heesakkers EM Adang GJ Jager S Strum YL Hoogeveen, et al. 2008 The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis Clin Radiol 63 4 387 95 18325358 10.1016/j.crad.2007.05.022 1:STN:280:DC%2BD1c7ms1yjsw%3D%3D
36. HU Ahmed A Kirkham M Arya R Illing A Freeman C Allen, et al. 2009 Is it time to consider a role for MRI before prostate biopsy? Nature reviews Clinical oncology [Review] 6 4 197 206 10.1038/nrclinonc.2009.18 The use of MRI before a biopsy can select for biopsy patients with significant cancer that requires treatment. In those with normal MRI, unnecessary biopsies and detection of insignificant and hence unnecessary over-treatment could be avoided
37. • Haffner J, Lemaitre L, Puech P, Haber GP, Leroy X, Jones JS, et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int. 2011 Mar 22. The strategy of targeted biopsies alone at prebiopsy MRI-suspicious areas is an attractive potential alternative to extended systematic biopsies for detection of significant prostate cancer.
38. B Djavan V Ravery A Zlotta P Dobronski M Dobrovits M Fakhari, et al. 2001 Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 166 5 1679 83 11586201 10.1016/S0022-5347(05)65652-2 1:STN:280:DC%2BD3MrjvFWgtw%3D%3D
39. T Hambrock DM Somford C Hoeks SA Bouwense H Huisman D Yakar, et al. 2010 Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen J Urol 183 2 520 7 20006859 10.1016/j.juro.2009.10.022 1:CAS:528:DC%2BC3cXitVSrt7c%3D MRI-guided biopsy of tumor-suspicious regions is an accurate method to detect clinically significant prostate cancer in men with repeat negative biopsies and increased PSA
40. Cornud F, Schull A, Beuvon F, Peyromaure M, Barry Delongchamps N. TRUS-MRI image fusion before initial biopsy in patients with a normal DRE and a PSA level <10 ng/ml. European Congress of Radiology, Vienna, abstract2011.
41. O Ukimura 2010 Evolution of precise and multimodal MRI and TRUS in detection and management of early prostate cancer Expert review of medical devices [Review] 7 4 541 54 10.1586/erd.10.24
42. • Baumann M, Mozer P, Daanen V, Troccaz J. Prostate biopsy tracking with deformation estimation. Medical image analysis. 2011 May 17. Prostate deformation was estimated with elastic registration. The system was robust with only 17 registration failures out of 786 (2%) biopsy volumes acquired from 47 patients during biopsy sessions. The article emphasizes the accuracy of deformation, which is required during TRUS-MRI image fusion.
43. C Tempany S Straus N Hata S Haker 2008 MR-guided prostate interventions J Magn Reson Imaging 27 2 356 67 18219689 10.1002/jmri.21259 (Pubitemid 351214042)
44. Macura KJ, Stoianovici D. Advancements in magnetic resonance-guided robotic interventions in the prostate. Topics in magnetic resonance imaging: TMRI. [Research Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov't Review]. 2008 Dec;19(6):297-304.
45. A Descazeaud M Peyromaure A Vieillefond D Bernard M Zerbib 2006 Does transrectal MRI before radical prostatectomy modify the operative technique to decrease the positive margin rate? Prog Urol 16 5 564 7 17175952 (Pubitemid 44852296)
46. AO Sartor H Hricak TM Wheeler J Coleman DF Penson PR Carroll, et al. 2008 Evaluating localized prostate cancer and identifying candidates for focal therapy Urology 72 6 Suppl S12 24 19095124 10.1016/j.urology.2008.10.004 The article refines the definition of the low-risk tumor with an adjustment of D'Amico criteria and inclusion of MRI findings
47. PS Tofts G Brix DL Buckley JL Evelhoch E Henderson MV Knopp, et al. 1999 Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols J Magn Reson Imaging 10 3 223 32 10508281 10.1002/(SICI)1522-2586(199909)10:3<223::AID- JMRI2>3.0.CO;2-S 1:STN:280:DyaK1Mvjsl2jtw%3D%3D (Pubitemid 29463104)